Could Versartis recover after today’s big decline?
A glimpse into recent investor meetings with management of Kratos Defense & Security.
A ‘game over’ for Versartis’ somavaratan; A powerful boost for Ascendis’ TC-hGH.
Thanks to a built-in marketing machine, the analyst believes new DIS streaming service will benefit.
Analyst says share weakness does not stem from encouraging news, but points to other underlying concerns.
Analyst praises Apple’s creative finesse at being able to separate itself from the rest of its rivals.
Analyst notes that regardless of which content is garnering Netflix’s viewers, subscribers keep joining.
Supernus investors are running for the hills, but analyst sees elimination of 18 mg dose as a good move.
How long will investors still hold out patience for Nike after two years of a “stale innovation pipeline?”
Though Teva shares took a hit upon the news, the analyst sees an upside to expectations in the distance.